ArticleBiomedicines2026

Evaluation of Early and Delayed Meloxicam Treatment Against Regulated Cell Death Pathways and ERK1/2 Phosphorylation in a Rat Model of Renal Ischemia-Reperfusion Injury.

Mahmut Şahin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.